Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$193.33 USD
-1.05 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $192.63 -0.70 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Company Summary
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Company Summary
General Information
Madrigal Pharmaceuticals, Inc
200 BARR HARBOR DRIVE SUITE 200
WEST CONSHOHOCKEN, PA 19428
Phone: 267-824-2827
Fax: 781-274-8228
Web: http://www.madrigalpharma.com
Email: ir@madrigalpharma.com
Industry | Medical - Drugs |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Earnings Date | 5/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -6.06 |
Current Year EPS Consensus Estimate | -21.86 |
Estimated Long-Term EPS Growth Rate | NA |
Earnings Date | 5/7/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 194.38 |
52 Week High | 322.67 |
52 Week Low | 119.76 |
Beta | NA |
20 Day Moving Average | 410,040.25 |
Target Price Consensus | 362.62 |
4 Week | -27.60 |
12 Week | -12.23 |
YTD | -16.44 |
4 Week | -25.41 |
12 Week | -14.67 |
YTD | -21.85 |
Shares Outstanding (millions) | 19.90 |
Market Capitalization (millions) | 3,846.77 |
Short Ratio | NA |
Last Split Date | 7/25/2016 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | NA |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | NA |
PEG Ratio | NA |
vs. Previous Year | -14.06% |
vs. Previous Quarter | -6.37% |
vs. Previous Year | NA% |
vs. Previous Quarter | NA% |
Price/Book | 9.42 |
Price/Cash Flow | NA |
Price / Sales | NA |
3/31/24 | NA |
12/31/23 | -219.39 |
9/30/23 | -293.56 |
3/31/24 | NA |
12/31/23 | -98.75 |
9/30/23 | -112.46 |
3/31/24 | NA |
12/31/23 | 5.38 |
9/30/23 | 2.36 |
3/31/24 | NA |
12/31/23 | 5.38 |
9/30/23 | 2.36 |
3/31/24 | NA |
12/31/23 | NA |
9/30/23 | NA |
3/31/24 | NA |
12/31/23 | NA |
9/30/23 | NA |
3/31/24 | NA |
12/31/23 | NA |
9/30/23 | NA |
3/31/24 | NA |
12/31/23 | 20.53 |
9/30/23 | 1.20 |
3/31/24 | NA |
12/31/23 | NA |
9/30/23 | NA |
3/31/24 | NA |
12/31/23 | 0.28 |
9/30/23 | 5.16 |
3/31/24 | NA |
12/31/23 | 22.17 |
9/30/23 | 83.76 |